Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Videos

Alexey Danilov, MD, PhD, Discusses the Use of Acalabrutinib for the Treatment of CLL, SLL, and MCL

 

In this video, Dr Danilov, Oregon Health & Science University, Portland, Oregon, discusses the use of acalabrutinib (Calquence; AstraZeneca) as a treatment option for patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and mantle cell lymphoma (MCL).

Advertisement

Advertisement

Advertisement

Advertisement